SCHEMBL272517

SCHEMBL272517

CC(C)Cn1c(=O)[nH]c(=O)c2[nH]c(C=O)nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 1/20 0.41
PDE1A P54750 3/20 0.41
PDE1B Q01064 3/20 0.41
PDE1C Q14123 3/20 0.41
PDE2A O00408 2/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPK1 P28482 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
PDE5A O76074 3/20 0.39
SIRT1 Q96EB6 1/20 0.39
SIRT3 Q9NTG7 1/20 0.39
SIRT5 Q9NXA8 1/20 0.39
ADORA2A P29274 2/20 0.38
ADORA2B P29275 2/20 0.38
ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5646 0.81 PDE2A (0.61) KDM4EALDH1A1HPGDPDE1APDE1B
SCHEMBL19583186 0.79 KDM4E (0.43) KDM4EALDH1A1HPGDPDE1APDE1B
SCHEMBL4796596 0.78 PDE1A (0.46) KDM4EALDH1A1HPGDPDE1APDE1B
SCHEMBL6234430 0.77 PDE5A (0.64) KDM4EALDH1A1HPGDPDE1APDE1B
SCHEMBL2053839 0.76 PDE5A (0.42) KDM4EALDH1A1HPGDPDE1APDE1B
SCHEMBL4623653 0.75 PDE5A (0.43) KDM4EALDH1A1HPGDPDE1APDE1B
SCHEMBL3110928 0.75 PNP (0.48) KDM4EALDH1A1HPGDPDE2AMEN1
SCHEMBL2954176 0.74 ADORA1 (0.51) KDM4EALDH1A1HPGDPDE1APDE1B
SCHEMBL9646522 0.74 KDM4E (0.44) KDM4EALDH1A1HPGDPDE1APDE1B
SCHEMBL7007230 0.73 MEN1 (0.50) KDM4EALDH1A1HPGDPDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10760049-B2 Generation of neural stem cells from undifferentiated human embryonic stem cells ES CELL INTERNATIONAL PTE LTD. (SG) 2020-09-01 US disclosed
US-20170335278-A1 GENERATION OF NEURAL STEM CELLS FROM UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS ES CELL INTERNATIONAL PTE LTD. (SG) 2017-11-23 US disclosed
US-9650605-B2 Generation of neural stem cells from undifferentiated human embryonic stem cells ES CELL INTERNATIONAL PTE LTD. (SG) 2017-05-16 US disclosed
EP-2652125-B1 INSULIN PRODUCING CELLS DERIVED FROM PLURIPOTENT STEM CELLS KADIMASTEM LTD (IL) 2017-04-26 EP disclosed
US-9404087-B2 Insulin producing cells derived from pluripotent stem cells KADIMASTEM LTD. (IL) 2016-08-02 US disclosed
EP-2652125-A1 INSULIN PRODUCING CELLS DERIVED FROM PLURIPOTENT STEM CELLS Kadimastem Ltd. (IL) 2013-10-23 EP disclosed
US-20130273013-A1 INSULIN PRODUCING CELLS DERIVED FROM PLURIPOTENT STEM CELLS KADIMASTEM LTD. (IL) 2013-10-17 US disclosed
WO-2012081029-A1 INSULIN PRODUCING CELLS DERIVED FROM PLURIPOTENT STEM CELLS KADIMASTEM LTD. (IL) 2012-06-21 WO disclosed
US-20120122211-A1 GENERATION OF NEURAL STEM CELLS FROM UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS ES CELL INTERNATIONAL PTE LTD. (SG) 2012-05-17 US disclosed
US-8133730-B2 Directing neural fate in a human neural progenitor cell hNPC in vitro by culturing the hNPC in the presence of a neural fate inducer selected from FGF-1, FGF-2, FGF-6, FGF-8, FGF-9, FGF-98, FGF-17, wherein the neural progenitor cell has been treated, prior to said culturing, with noggin ES CELL INTERNATIONAL PTE LTD (SG) 2012-03-13 US disclosed
EP-2360241-A1 Stem cells ES Cell International Pte Ltd. (SG) 2011-08-24 EP disclosed
EP-2327762-A1 Stem cells ES Cell International Pte Ltd. (SG) 2011-06-01 EP disclosed
US-7604992-B2 Generation of neural stem cells from undifferentiated human embryonic stem cells ES CELL INTERNATIONAL PTE LTD. (SG) 2009-10-20 US disclosed
US-20090004736-A1 GENERATION OF NEURAL STEM CELLS UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS ES CELL INTERNATIONAL PTE LTD. (SG) 2009-01-01 US disclosed
US-20050255589-A1 Directing neural fate in a human neural progenitor cell hNPC in vitro by culturing the hNPC in the presence of a neural fate inducer selected from FGF-1, FGF-2, FGF-6, FGF-8, FGF-9, FGF-98, FGF-17, wherein the neural progenitor cell has been treated, prior to said culturing, with noggin ES CELL INTERNATIONAL PTE LTD. (SG) 2005-11-17 US disclosed
EP-1511839-A4 GENERATION OF NEURAL STEM CELLS FROM UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS ES CELL INT PTE LTD (SG) 2005-11-16 EP disclosed
EP-1511839-A1 GENERATION OF NEURAL STEM CELLS FROM UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS ES Cell International Pte Ltd. (SG) 2005-03-09 EP disclosed
WO-2003104444-A1 GENERATION OF NEURAL STEM CELLS FROM UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS ES CELL INTERNATIONAL PTE LTD (AU) 2003-12-18 WO disclosed